Aura Biosciences Inc Sustainability Reports
Aura Biosciences Inc. is a clinical-stage biotechnology company focused on developing precision immunotherapies and therapies for solid tumors. Its proprietary Virus-Like Drug Conjugate technology is primarily utilized to design targeted treatments that kill tumor cells while preserving organ function.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00226DGP2
2 reports from 2021 to 2024
Company Profile
Aura Biosciences Inc. is a clinical-stage biotechnology company focused on developing precision immunotherapies and therapies for solid tumors. Its proprietary Virus-Like Drug Conjugate technology is primarily utilized to design targeted treatments that kill tumor cells while preserving organ function.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
